Immunologic profile of human immunodeficiency virus-infected patients during viral remission and relapse on antiretroviral therapy.
暂无分享,去创建一个
M. Wellons | J. Bartlett | K. Weinhold | J. Ottinger | L. Sanders | L. Edwards | J. Thomasch | M. E. Gooding | V. Gryszowka
[1] R. Grant,et al. Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection. , 2000, The Journal of infectious diseases.
[2] M. Lederman,et al. Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen , 2000, AIDS.
[3] B. Haynes,et al. The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. , 2000, Annual review of immunology.
[4] J V Giorgi,et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. , 1999, The Journal of infectious diseases.
[5] A. Telenti,et al. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study , 1999, The Lancet.
[6] Gea-Banacloche Jc,et al. Immune reconstitution in HIV infection. , 1999 .
[7] J. Gea-Banacloche,et al. Immune reconstitution in HIV infection. , 1999, AIDS.
[8] Louis J. Picker,et al. Changes in thymic function with age and during the treatment of HIV infection , 1998, Nature.
[9] R. Detels,et al. Immunologic effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic HIV‐1 infection , 1998, AIDS.
[10] R. Detels,et al. CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[11] Rob J. De Boer,et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation , 1998, Nature Medicine.
[12] J Leibowitch,et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. , 1997, Science.
[13] H. Schuitemaker,et al. Viro‐immunological studies in acute HIV‐1 infection , 1994, AIDS.
[14] R. Detels,et al. T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study. , 1989, Clinical immunology and immunopathology.